Latest News - #Andrey Ivashchenko

In Chemrar, commented on the failure of tests of "Favipiravir" in Japan

The results of studies in Japan "by Favipiravir" which is used in Russia for the treatment of coronavirus, are preliminary and do not allow to make definite conclusions about the effectiveness or ineffectiveness of the drug, said the Chairman of the Board of Directors of "Khimrar" Andrey Ivashchenko.

Agency Kyodo earlier reported that the specialists of the Institute of public health Fujita on the results of clinical trials of the drug "Avigan" ("Favipiravir", "Failover") could not confirm its effectiveness. The Russian direct investment Fund (RDIF) and Chemrar produce a drug called "Aviewer" in Russia.